Note: mucinous/KRAS is also prevalant in colorectal cancers
Conclusions
Primary mucinous ovarian cancer should
be considered separate from the other epithelial ovarian cancers.
Ongoing clinical trials in this disease will likely offer improvements
in chemotherapeutic agents used to treat women with primary and
recurrent mucinous ovarian cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.